Analysts expect that Senseonics Holdings, Inc. (NASDAQ:SENS) will post ($0.16) earnings per share (EPS) for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Senseonics’ earnings, with estimates ranging from ($0.17) to ($0.14). Senseonics also reported earnings per share of ($0.16) during the same quarter last year. The company is scheduled to issue its next earnings results on Wednesday, August 14th.
On average, analysts expect that Senseonics will report full year earnings of ($0.65) per share for the current financial year, with EPS estimates ranging from ($0.67) to ($0.59). For the next financial year, analysts expect that the business will report earnings of ($0.52) per share, with EPS estimates ranging from ($0.57) to ($0.45). Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow Senseonics.
Senseonics (NASDAQ:SENS) last released its earnings results on Thursday, May 9th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.05). The business had revenue of $3.42 million during the quarter, compared to analysts’ expectations of $4.05 million.
Shares of NASDAQ SENS traded down $0.11 during mid-day trading on Tuesday, reaching $1.62. 1,831,496 shares of the company’s stock were exchanged, compared to its average volume of 1,628,998. The firm’s fifty day moving average is $1.95. Senseonics has a twelve month low of $1.62 and a twelve month high of $4.89.
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Recommended Story: How interest rates affect municipal bond prices
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.